Evidence mapPaperPMID 37285600Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2023

Effects of acute changes in fasting glucose and free fatty acid concentrations on indices of β-cell function and glucose metabolism in subjects without diabetes.

Daniel Schembri Wismayer, Marcello C Laurenti, Yilin Song, Aoife M Egan, Andrew A Welch, Kent R Bailey, Claudio Cobelli, Chiara Dalla Man, Michael D Jensen, Adrian Vella

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Daniel Schembri WismayerDivision of Endocrinology, Diabetes & Metabolism, Mayo Clinic College of Medicine, Rochester, Minnesota, United States.
Marcello C LaurentiBiomedical Engineering and Physiology Graduate Program, Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota, United States.ORCID 0000-0002-8697-6260
Yilin SongDivision of Endocrinology, Diabetes & Metabolism, Mayo Clinic College of Medicine, Rochester, Minnesota, United States.
Aoife M EganDivision of Endocrinology, Diabetes & Metabolism, Mayo Clinic College of Medicine, Rochester, Minnesota, United States.
Andrew A WelchDivision of Endocrinology, Diabetes & Metabolism, Mayo Clinic College of Medicine, Rochester, Minnesota, United States.
Kent R BaileyDivision of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, United States.
Claudio CobelliDepartment of Woman and Child's Health, University of Padova, Padova, Italy.
Chiara Dalla ManDepartment of Information Engineering, University of Padova, Padova, Italy.ORCID 0000-0002-4908-0596
Michael D JensenDivision of Endocrinology, Diabetes & Metabolism, Mayo Clinic College of Medicine, Rochester, Minnesota, United States.ORCID 0000-0001-5589-8389
Adrian VellaDivision of Endocrinology, Diabetes & Metabolism, Mayo Clinic College of Medicine, Rochester, Minnesota, United States.ORCID 0000-0001-6493-7837
Mayo Clinic · USUniversity of Padua · ITMayo Clinic in Florida · US

Funding

REGIONAL FATTY ACID METABOLISM IN HUMANSR01DK045343 · MAYO CLINIC ROCHESTER · 1992 to 2025
$3.2M
FFA METABOLISM IN DIFFERENT TYPES OF HUMAN OBESITYR01DK040484 · MAYO CLINIC ROCHESTER · 1993 to 2025
$1.5M
FFA Metabolism in Different Types of Human ObesityR37DK040484 · MAYO CLINIC COLL OF MEDICINE, ROCHESTER · 2003 to 2005
$1.1M
The effect of endogenous GLP-1 secretion on islet function in vivoR01DK126206 · MAYO CLINIC ROCHESTER · 2025 to 2025
$743k
The regulation of fasting glucose metabolism in people with and without prediabetesR01DK078646 · MAYO CLINIC ROCHESTER · 2025 to 2025
$667k
Glucagon secretion and action in humansR01DK116231 · MAYO CLINIC ROCHESTER · 2025 to 2025
$520k
NCATS NIH HHS UL1 TR000135NIDDK NIH HHS R01 DK040484NIDDK NIH HHS R01 DK045343NIDDK NIH HHS R01 DK078646NIDDK NIH HHS R01 DK116231NIDDK NIH HHS R01 DK126206NIDDK NIH HHS R37 DK040484
6 · The paper itself

Abstract

Elevated fasting free fatty acids (FFAs) and fasting glucose are additively associated with impaired glucose tolerance (IGT) and decreased β-cell function [quantified as disposition index (DI)]. We sought to examine how changes in fasting FFA and glucose alter islet function. We studied 10 subjects with normal fasting glucose (NFG) and normal glucose tolerance (NGT) on two occasions. On one occasion, Intralipid and glucose were infused overnight to mimic conditions present in IFG/IGT. In addition, we studied seven subjects with IFG/IGT on two occasions. On one occasion, insulin was infused to lower overnight FFA and glucose concentrations to those observed in people with NFG/NGT. The following morning, a labeled mixed meal was used to measure postprandial glucose metabolism and β-cell function. Elevation of overnight fasting FFA and glucose in NFG/NGT did not alter peak or integrated glucose concentrations (2.0 ± 0.1 vs. 2.0 ± 0.1 Mol per 5 h, Saline vs. Intralipid/glucose,

Indexed as

Diabetes MellitusGlucose IntoleranceInsulin ResistanceBlood GlucoseFatty Acids, NonesterifiedGlucoseHumansInsulinBlood GlucoseFatty Acids, NonesterifiedGlucoseInsulinimpaired fasting glucoseimpaired insulin actioninsulin secretionα-cell functionβ-cell function

Identifiers

PMID37285600
PMCPMC10393375
OpenAlexW4379617443

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.